Study shows promising results for Chembio's syphilis test

12/16/2012 | GenomeWeb Daily News (free registration)

Chembio Diagnostics reported positive trial results for a point-of-care syphilis test that runs on its Dual Path Platform. The trial, which involved 3,134 samples, found the test was able to detect syphilis antibodies with sensitivities and specificities of 96.7% and 99.3% respectively in whole blood, 96.4% and 99.1% in finger prick blood, 94.6% and 99.6% in blood plasma.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT